13F reference period
Q2 2026
Security Snapshot
Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) Institutional Ownership
CUSIP: 87990A106
13F Institutional Holders and Ownership History from Q3 2021 to Q3 2026
Institutions Reporting
101
Shares (Excl. Options)
53.73M
Full value: 53,734,311 · shares · 30 Jun 2026Price
$0.74
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- TNYA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 53,734,311
- Total 13F value
- $39,721,640
- Portfolio coverage rank
- 0%
- Share change
- -523,197
- Value change
- -$198,851
- Number of holders
- 101
- Shares outstanding
- 222,722,404
- SEC-reported price per share
- $0.57
- Insider filing price
- $0.57
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 87990A106.
- 101 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 103 to 101 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$37.51M
Full value: $37,512,767 · USD · 31 Mar 2026.$39.72M
Full value: $39,721,640 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 101 institutions filings for Q2 2026.
Security key
87990A106
13F reference period
Q2 2026
13F holders
101
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
TNYA full holder history
Tenaya Therapeutics, Inc. SEC filings
Tenaya Therapeutics, Inc. company facts
Tenaya Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 87990A106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
TNYA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC | 5.2% | $8,570,358 | 11,581,565 | Millennium Management LLC | 17 Aug 2026 | |||
| Woodline Partners LP | 5% | -26% | $6,120,000 | +$2,097,006 | 9,000,000 | +52% | Woodline Partners LP | 30 Jun 2025 |
| Empery Asset Management, LP | 5% | -50% | $5,641,468 | -$293,106 | 8,296,276 | -4.9% | Empery Asset Management, LP | 30 Jun 2025 |
| Casdin Capital, LLC | 4.3% | $3,231,826 | 6,732,971 | Casdin Capital, LLC | 04 Mar 2025 | |||
| BlackRock, Inc. | 1.7% | -71% | $1,670,287 | -$1,566,919 | 2,732,800 | -48% | BlackRock, Inc. | 30 Jun 2025 |
| JPMORGAN CHASE & CO | 2.8% | -53% | $1,096,279 | -$1,378,097 | 2,283,914 | -56% | JPMORGAN CHASE & CO. | 28 Feb 2025 |
As of 30 Jun 2026,
101
institutional investors reported holding
shares of
Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA).
This represents
24%
of the company’s total
outstanding shares.
53.73M
Full value: 53,734,311 · shares · 30 Jun 2026222.72M
Full value: 222,722,404 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.2% | 7,101,263 | -16% | 0% | $5,247,833 |
| MILLENNIUM MANAGEMENT LLC | 2.9% | 6,429,648 | +18% | 0% | $4,752,153 |
| CITADEL ADVISORS LLC | 2.1% | 4,566,774 | +8.7% | 0% | $3,375,303 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 4,281,100 | +15% | 0% | $3,164,161 |
| BlackRock, Inc. | 1.8% | 4,008,719 | +8.2% | 0% | $2,962,845 |
| Empery Asset Management, LP | 1.7% | 3,863,115 | -9.9% | 3.3% | $2,855,228 |
| MARSHALL WACE, LLP | 1.6% | 3,503,178 | +29% | 0% | $2,592,352 |
| GSA CAPITAL PARTNERS LLP | 1.2% | 2,669,033 | +149% | 0.12% | $1,973,000 |
| Burkehill Global Management, LP | 0.9% | 2,000,000 | 0% | 0.05% | $1,478,200 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.82% | 1,834,674 | +18% | 0% | $1,356,805 |
| ADAR1 Capital Management, LLC | 0.7% | 1,555,500 | +3.2% | 0.05% | $1,149,670 |
| Raiffeisen Bank International AG | 0.54% | 1,200,000 | +20% | 0.01% | $881,880 |
| Euclidean Capital LLC | 0.46% | 1,015,705 | 0% | 0.17% | $750,708 |
| VANGUARD FIDUCIARY TRUST CO | 0.44% | 987,505 | -2.8% | 0% | $729,766 |
| Mirador Capital Partners LP | 0.41% | 905,097 | +2% | 0.08% | $668,957 |
| STATE STREET CORP | 0.32% | 708,721 | 0% | 0% | $523,816 |
| Squarepoint Ops LLC | 0.3% | 659,247 | +89% | 0% | $487,249 |
| StepStone Group LP | 0.21% | 462,163 | 0% | 0.02% | $341,538 |
| UBS Group AG | 0.2% | 456,555 | -31% | 0% | $337,394 |
| JANE STREET GROUP, LLC | 0.2% | 450,435 | -62% | 0% | $332,917 |
| TWO SIGMA INVESTMENTS, LP | 0.17% | 380,790 | -70% | 0% | $281,442 |
| Casdin Capital, LLC | 0.16% | 361,969 | 0% | 0.01% | $267,531 |
| Invesco Ltd. | 0.16% | 354,862 | +157% | 0% | $262,279 |
| NORTHERN TRUST CORP | 0.16% | 346,371 | +11% | 0% | $256,003 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.15% | 325,316 | +5.4% | 0% | $240,441 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Headline period
Q2 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 1,385,901 | $831,436 | +$62,375 | $0.60 | 16 |
| 2026 Q2 | 53,734,311 | $39,721,640 | -$198,851 | $0.74 | 101 |
| 2026 Q1 | 54,305,766 | $37,512,767 | -$10,991,288 | $0.69 | 103 |
| 2025 Q4 | 68,535,823 | $48,758,847 | +$17,052,952 | $0.71 | 97 |
| 2025 Q3 | 34,529,364 | $55,547,747 | +$5,381,496 | $1.62 | 89 |
| 2025 Q2 | 31,571,002 | $19,291,816 | -$9,941,570 | $0.61 | 87 |
| 2025 Q1 | 48,166,604 | $27,453,207 | +$1,982,469 | $0.57 | 104 |
| 2024 Q4 | 43,606,618 | $62,359,118 | -$25,849,595 | $1.43 | 83 |
| 2024 Q3 | 57,630,896 | $111,228,656 | +$67,017 | $1.93 | 91 |
| 2024 Q2 | 57,076,933 | $176,981,415 | +$2,253,617 | $3.10 | 94 |
| 2024 Q1 | 56,023,483 | $292,935,438 | +$51,188,426 | $5.23 | 89 |
| 2023 Q4 | 46,629,309 | $151,075,893 | -$9,232,276 | $3.24 | 73 |
| 2023 Q3 | 49,741,215 | $126,838,955 | -$3,313,935 | $2.55 | 77 |
| 2023 Q2 | 47,651,950 | $279,717,125 | +$15,890,634 | $5.87 | 79 |
| 2023 Q1 | 45,028,141 | $128,326,772 | -$2,290,501 | $2.85 | 65 |
| 2022 Q4 | 47,128,809 | $94,724,321 | +$22,977,493 | $2.01 | 67 |
| 2022 Q3 | 35,221,703 | $102,151,001 | -$12,249,474 | $2.90 | 67 |
| 2022 Q2 | 37,062,342 | $208,638,443 | -$1,855,716 | $5.63 | 47 |
| 2022 Q1 | 37,349,150 | $439,920,087 | +$23,331,598 | $11.78 | 50 |
| 2021 Q4 | 35,354,543 | $667,600,957 | +$18,069,398 | $18.95 | 46 |
| 2021 Q3 | 24,450,664 | $499,284,447 | +$499,284,447 | $20.65 | 44 |